|
CNOT4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.250440E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.664230E-01 |
| Normal-vs-Stage2 |
6.441400E-01 |
| Normal-vs-Stage3 |
2.302200E-02 |
| Normal-vs-Stage4 |
4.47989999999843E-05 |
| Stage1-vs-Stage2 |
8.261600E-01 |
| Stage1-vs-Stage3 |
2.161600E-01 |
| Stage1-vs-Stage4 |
5.758400E-04 |
| Stage2-vs-Stage3 |
3.031800E-01 |
| Stage2-vs-Stage4 |
3.682000E-02 |
| Stage3-vs-Stage4 |
1.026570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.182030E-01 |
| Normal-vs-AfricanAmerican |
2.125800E-01 |
| Normal-vs-Asian |
1.985430E-01 |
| Caucasian-vs-AfricanAmerican |
8.665800E-01 |
| Caucasian-vs-Asian |
7.946400E-01 |
| AfricanAmerican-vs-Asian |
8.446600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.171700E-02 |
| Normal-vs-Female |
7.082600E-01 |
| Male-vs-Female |
3.384400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.429590E-01 |
| Normal-vs-Extreme_Weight |
4.867600E-02 |
| Normal-vs-Obese |
3.327400E-01 |
| Normal-vs-Extreme_Obese |
3.746200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.602000E-01 |
| Normal_Weight-vs-Obese |
4.479800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.999200E-01 |
| Extreme_Weight-vs-Obese |
3.087200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.768200E-01 |
| Obese-vs-Extreme_Obese |
5.861200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.317800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.597400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.085000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.296600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.265000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.219000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.445800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.047620E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.595240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.215000E-01 |
| Normal-VS-Type2 PRCC |
3.556600E-04 |
| Normal-VS-KIRP CIMP |
1.022980E-03 |
| Normal-VS-Unclassified PRCC |
7.345400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.06060000000386E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.435600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.976200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.821800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.178100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.200500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.413400E-04 |
| Normal-vs-N1 |
1.268400E-01 |
| Normal-vs-N2 |
1.044230E-03 |
| N0-vs-N1 |
2.130400E-01 |
| N0-vs-N2 |
3.334400E-02 |
| N1-vs-N2 |
5.181200E-03 |
|
|
